These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30847368)

  • 61. Unfavorable neurological outcome in diabetic patients with acute ischemic stroke is associated with incomplete recanalization after intravenous thrombolysis.
    Tang H; Zhang S; Yan S; Liebeskind DS; Sun J; Ding X; Zhang M; Lou M
    J Neurointerv Surg; 2016 Apr; 8(4):342-6. PubMed ID: 25735852
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Sex Differences and Functional Outcome After Intravenous Thrombolysis.
    Spaander FH; Zinkstok SM; Baharoglu IM; Gensicke H; Polymeris A; Traenka C; Hametner C; Ringleb P; Curtze S; Martinez-Majander N; Aarnio K; Nolte CH; Scheitz JF; Leys D; Hochart A; Padjen V; Kägi G; Pezzini A; Michel P; Bill O; Zini A; Engelter ST; Nederkoorn PJ;
    Stroke; 2017 Mar; 48(3):699-703. PubMed ID: 28143921
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Exclusion criteria for intravenous thrombolysis in stroke mimics: an observational study.
    Brunser AM; Illanes S; Lavados PM; Muñoz P; Cárcamo D; Hoppe A; Olavarria VV; Delgado I; Díaz V
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1140-5. PubMed ID: 23253534
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prognostic Values of Prothrombin Time and Inflammation-Related Parameter in Acute Ischemic Stroke Patients After Intravenous Thrombolysis with rt-PA.
    Zhao J; Dong L; Hui S; Lu F; Xie Y; Chang Y; Yang B
    Clin Appl Thromb Hemost; 2023; 29():10760296231198042. PubMed ID: 37670481
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Evaluation of the role of susceptibility-weighted imaging in thrombolytic therapy for acute ischemic stroke.
    Zhao G; Sun L; Wang Z; Wang L; Cheng Z; Lei H; Yang D; Cui Y; Zhang S
    J Clin Neurosci; 2017 Jun; 40():175-179. PubMed ID: 28228323
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
    García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
    Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Remote ischemic perconditioning in thrombolysed stroke patients: randomized study of activating endogenous neuroprotection - design and MRI measurements.
    Hougaard KD; Hjort N; Zeidler D; Sørensen L; Nørgaard A; Thomsen RB; Jonsdottir K; Mouridsen K; Hansen TM; Cho TH; Nielsen TT; Bøtker HE; Østergaard L; Andersen G
    Int J Stroke; 2013 Feb; 8(2):141-6. PubMed ID: 22463392
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke.
    Al-Khaled M; Matthis C; Eggers J
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):7-11. PubMed ID: 22578915
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ten-Year Evaluation of the TOYOTA Prehospital Stroke Scale for Tissue Plasminogen Activator Intravenous Therapy in the Real World.
    Suzuki J; Nakai N; Kondo N; Tsuji H; Inagaki R; Furukawa S; Iwata M; Nishida S; Ito Y
    Cerebrovasc Dis; 2018; 46(3-4):184-192. PubMed ID: 30384371
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
    Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
    Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Generalization of the right acute stroke promotive strategies in reducing delays of intravenous thrombolysis for acute ischemic stroke: A meta-analysis.
    Huang Q; Zhang JZ; Xu WD; Wu J
    Medicine (Baltimore); 2018 Jun; 97(25):e11205. PubMed ID: 29924046
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Circadian rhythms may not influence the outcomes of thrombolysis in patients with ischemic stroke: A study from China.
    Ding J; Bai Z; Zhou D; Li X; Rajah GB; Ding Y; Han J; Ji X; Meng R
    Chronobiol Int; 2018 Oct; 35(11):1533-1542. PubMed ID: 29993298
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Intravenous thrombolysis in ischemic stroke: Therapeutic perspectives].
    Paris C; Derex L
    Rev Neurol (Paris); 2015 Dec; 171(12):866-75. PubMed ID: 26563662
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The efficacy of intravenous thrombolysis in acute ischemic stroke patients with white matter hyperintensity.
    Liu Y; Zhang M; Bao H; Zhang Z; Mei Y; Yun W; Zhou X
    Brain Behav; 2018 Dec; 8(12):e01149. PubMed ID: 30378299
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Safety and efficacy of remote ischemic conditioning combined with intravenous thrombolysis for acute ischemic stroke: A multicenter, randomized, parallel-controlled clinical trial (SERIC-IVT) Study design and protocol.
    Abuduxukuer R; Guo ZN; Zhang P; Qu Y; Yang Y
    Int J Stroke; 2023 Mar; 18(3):370-374. PubMed ID: 35619218
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Minor Nonintracranial Hemorrhage and Poor Prognosis among Stroke Patients Undergoing Intravenous Thrombolysis.
    Qin X; Zhao S; Yin L; Dou H; Chen J; Wang Y; Li M; Chen R; Yang G; Liu X; Wang R; Jia X; Bu S; Ma D; Wang B; Li S
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2383-2386. PubMed ID: 28624140
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Older age is not related to hemorrhagic transformation and favorable outcomes in patients with wake-up ischemic stroke undergoing intravenous thrombolytic therapy].
    Zhai LP; Chen ZC; Yan SQ; Zhong GL; Zhang S; Xu MJ; Lou M
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2015 Nov; 44(6):638-44. PubMed ID: 26822046
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Safety of Early Carotid Endarterectomy after Intravenous Thrombolysis in Acute Ischemic Stroke.
    Gunka I; Krajickova D; Lesko M; Renc O; Raupach J; Jiska S; Lojik M; Chovanec V; Maly R
    Ann Vasc Surg; 2017 Oct; 44():353-360. PubMed ID: 28479465
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Intravenous thrombolysis for patients with in-hospital stroke onset: propensity-matched analysis from the Safe Implementation of Treatments in Stroke-East registry.
    Tsivgoulis G; Katsanos AH; Kadlecová P; Czlonkowska A; Kobayashi A; Brozman M; Švigelj V; Csiba L; Fekete K; Kõrv J; Demarin V; Vilionskis A; Jatuzis D; Krespi Y; Karapanayiotides T; Giannopoulos S; Mikulik R
    Eur J Neurol; 2017 Dec; 24(12):1493-1498. PubMed ID: 28888075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.